TABLE 3.
Disease severity of patients hospitalized for COVID‐19 a
| MAB b patients (N = 8) | Comparator patients (N = 11) | |
|---|---|---|
| WHO c criteria | ||
| Non‐severe disease | 3 (37.5) | 2 (18.2) |
| Severe disease | 4 (50) | 8 (72.7) |
| Critical disease | 1 (12.5) | 1 (9.1) |
| Intensive care unit stay | 2 (25) | 1 (9.1) |
| Intubation | 1 (12.5) | 0 (0) |
| Acute kidney injury | 6 (75) | 4 (36.4) |
| Renal replacement therapy | 0 (0) | 1 (9.1) |
| Initial laboratory results | ||
| Lymphocyte count, x103/mcl | 0.64 (0.37–0.70) | 0.67 (0.28–0.78) |
| C‐Reactive Protein, mg/L | 109 (56–182) | 72 (33–118) |
| Ferritin, ng/ml | 770 (250–2121) | 453 (308–1657) |
| Procalcitonin, ng/ml | 0.25 (0.15–0.34) | 0.16 (0.10–0.29) |
| Serum creatinine, mg/dl | 1.79 (1.54–2.27) | 1.97 (1.17–2.21) |
| Length of hospital stay, days | 4 (2.5–9.5) | 8 (3‐8) |
| Discharged on oxygen | 3 (37.5) | 5 (45.5) |
| Death | 0 | 2 (18.2) |
Note: Values are expressed as frequencies (percentages) for categorical variables and medians (interquartile ranges) for continuous variables.
a
Coronavirus disease 2019.
b
Monoclonal antibody.
c
World Health Organization.